Dr. Elias Dakwar sought proof of the suggestion that concentrated doses of ketamine may help reduce vulnerabilities associated with cocaine use, and improve the likelihood of relapse prevention.
Dr. Elizabeth Fitelson discusses what we can expect from brexanolone, a drug developed specifically to counteract unique physiologic changes that can induce postpartum depression in vulnerable women.
“College aged youth are among the most vulnerable to the onset of many mental disorders — including anxiety, mood, eating, psychotic and substance-use disorders,” writes Dr. Jeffrey A. Lieberman.
“These clinical trials are different from grow-your-own psilocybin mushrooms from a bunch of spores and take the mushroom at home or at a concert,” Dr. David Hellerstein said.
Dr. Cristiane S. Duarte pointed out limitations in the study, such as cultural variation and scarcity of data in conflict-affected settings, that should be addressed in future research.
Dr. Alan S. Brown says the study provides evidence that a mother’s smoking during pregnancy could be related to the later development of ADHD in their infant.
“As we treat more people with ketamine, an unfortunate side effect of that is more exposure, which means that we're going to create more ketamine addicts,” said Dr. Drew Ramsey.
